Orbimed Advisors LLC Ironwood Pharmaceuticals Inc Transaction History

Orbimed Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$8.27 - $12.73 $23.8 Million - $36.6 Million	-2,878,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$7.8 - $16.13 $399,750 - $826,662	-51,250 Reduced 1.75%	2,878,000 $29.8 Million
Q1 2018 May 15, 2018	SELL	$11.13 - $13.63 $17.8 Million - $21.8 Million	-1,595,950 Reduced 35.27%	2,929,250 $45.2 Million
Q4 2017 Feb 14, 2018	SELL	$12.16 - $14.58 $15 Million - $18 Million	-1,234,000 Reduced 21.43%	4,525,200 $67.8 Million
Q3 2017 Nov 14, 2017	BUY	$12.07 - $14.87 $69.5 Million - $85.6 Million	5,759,200	5,759,200 $90.8 Million

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.